Adagio Therapeutics
Adagio is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional potentially emergent coronaviruses.
Rankings by
Национальный рейтинг414th
in United States Региональный рейтинг470th
in North America and Caribbean Глобальный рейтинг1129th
worldwide